Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H40N4.3ClH |
Molecular Weight | 518.005 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.Cl.CC1(CCCCCCC1)N2CCC(CC2)N3C(=NC4=CC=CC=C34)[C@@H]5CCCNC5
InChI
InChIKey=DTIPEVOPCGEULQ-RFCADEKQSA-N
InChI=1S/C26H40N4.3ClH/c1-26(15-7-3-2-4-8-16-26)29-18-13-22(14-19-29)30-24-12-6-5-11-23(24)28-25(30)21-10-9-17-27-20-21;;;/h5-6,11-12,21-22,27H,2-4,7-10,13-20H2,1H3;3*1H/t21-;;;/m1.../s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C26H40N4 |
Molecular Weight | 408.6226 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
MCOPPB trihydrochloride (MCOPPB) is a nonpeptide agonist of the NOP receptor, an anxiolytic agent. MCOPPB has a high affinity for the human NOP receptor (pKi = 10.07 +/- 0.01) and selectivity for the NOP receptor over other members of the opioid receptor family: 12-, 270- and >1000-fold more selective for the NOP receptor than for the micro-, kappa-, and delta-receptor, respectively. In an ex vivo binding study, MCOPPB (10 mg/kg, p.o.) inhibited signaling through the NOP receptor in the mouse brain, suggesting that it penetrated into the brain after it was orally administered. MCOPPB - a compound with few adverse effects on the central nervous system - is a potential therapeutic agent for the treatment of anxiety.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18319566 | https://www.ncbi.nlm.nih.gov/pubmed/19125610
Curator's Comment: # Pfizer Inc., Japan
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18319566
Mice: In the mouse Vogel conflict test, MCOPPB trihydrochloride (10 mg/kg, p.o.) and diazepam (3 mg/kg, p.o.) elicited anxiolytic-like effects, although MCOPPB trihydrochloride produced a bell-shaped response curve. In addition, MCOPPB (10 mg/kg, p.o.) was still effective as an anxiolytic agent even after repeated administration for 5 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19125610
EC50 value of the MCOPPB trihydrochloride (MCOPPB) for the activity of [35S]GTPγS binding in response to the respective agonist–hNOP receptor binding in HEK293 cells was 0.0858 nM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:40:04 GMT 2023
by
admin
on
Sat Dec 16 15:40:04 GMT 2023
|
Record UNII |
SIO8DBP4K7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
25208093
Created by
admin on Sat Dec 16 15:40:04 GMT 2023 , Edited by admin on Sat Dec 16 15:40:04 GMT 2023
|
PRIMARY | |||
|
1108147-88-1
Created by
admin on Sat Dec 16 15:40:04 GMT 2023 , Edited by admin on Sat Dec 16 15:40:04 GMT 2023
|
PRIMARY | |||
|
SIO8DBP4K7
Created by
admin on Sat Dec 16 15:40:04 GMT 2023 , Edited by admin on Sat Dec 16 15:40:04 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |